Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Change in Cash: 2016-2024

Historic Change in Cash for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to $23.0 million.

  • Arcus Biosciences' Change in Cash fell 122.22% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 117.65%. This contributed to the annual value of $23.0 million for FY2024, which is 129.11% up from last year.
  • Arcus Biosciences' Change in Cash amounted to $23.0 million in FY2024, which was up 129.11% from -$79.0 million recorded in FY2023.
  • Arcus Biosciences' 5-year Change in Cash high stood at $116.0 million for FY2020, and its period low was -$79.0 million during FY2023.
  • Its 3-year average for Change in Cash is $666,667, with a median of $23.0 million in 2024.
  • As far as peak fluctuations go, Arcus Biosciences' Change in Cash spiked by 983.67% in 2020, and later plummeted by 236.21% in 2023.
  • Yearly analysis of 5 years shows Arcus Biosciences' Change in Cash stood at $116.0 million in 2020, then slumped by 119.83% to -$23.0 million in 2021, then skyrocketed by 352.17% to $58.0 million in 2022, then slumped by 236.21% to -$79.0 million in 2023, then soared by 129.11% to $23.0 million in 2024.